Author:
Tsuchiya Kiyoto,Matsuoka-Aizawa Saori,Yasuoka Akira,Kikuchi Yoshimi,Tachikawa Natsuo,Genka Ikumi,Teruya Katsuji,Kimura Satoshi,Oka Shinichi
Subject
Infectious Diseases,Virology
Reference32 articles.
1. Clinical benefits of resistance assay for HIV-specific protease inhibitors: when to check and in whom?;Aizawa;AIDS,1999
2. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection;Albrecht;New Engl. J. Med.,2001
3. Division of AIDS. Division of AIDS table for grading severity of adult adverse experience. Rockville, MD: National Institute of Allergy and Infectious Diseases, 1996.
4. Comparison of virologic, immunologic, and clinical response of five different initial protease inhibitor-containing and nevirapine-containing regimens;Easterbrook;J. Aquir. Immune Defic. Syndr.,2001
5. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicenter study;Egger;Br. Med. J.,1997
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献